Reading Time: 4 minutesDiagnosing disease faster, accurately predicting disease progression, assessing the ability of a new drug to reach its target – I think we’d all agree that
Search Results for: clinical trial
32nd Symposium: Virtual 32nd Symposium: Virtual Clinical Trials MND Research Research we fund Symposium Treatments
Symposium Spotlight: A closer look at IMODALS clinical trial outcomes
Reading Time: 6 minutesAs the research team are starting to get stuck into planning our next International Symposium on ALS/MND we are taking a look back at some
Reading Time: 4 minutesResearchers at King’s College London led by Professor Christopher Shaw, are the first in Europe to embark on a clinical trial targeting a specific genetic
Reading Time: 4 minutesThis is blog number 20 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 5 minutesThis is blog number 19 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 4 minutesThis is blog number 18 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 3 minutesThis is the first in a series of three blog articles from Session 7 – Perspectives: Lessons from COVID-19 in which we heard from different
Reading Time: 2 minutesThis blog is part of the ‘Virtual Highlights’ collection of articles, where you can read about the content of some of the talks and posters
Reading Time: 4 minutesThis blog is part of the ‘Virtual Highlights’ collection of articles, where you can read about the content of some of the talks and posters
The ‘gold standard’ for determining if a new drug is safe and effective to be used to treat disease. Clinical trials must be successfully completed